89 related articles for article (PubMed ID: 14632602)
21. Antipsychotic agents in the treatment of bipolar mania.
Tohen M; Vieta E
Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics.
Citrome L; Collins JM; Nordstrom BL; Rosen EJ; Baker R; Nadkarni A; Kalsekar I
J Clin Psychiatry; 2013 Dec; 74(12):1199-206. PubMed ID: 24434088
[TBL] [Abstract][Full Text] [Related]
23. Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.
Gianfrancesco F; Pesa J; Wang RH; Nasrallah H
Am J Health Syst Pharm; 2006 Mar; 63(5):431-41. PubMed ID: 16484517
[TBL] [Abstract][Full Text] [Related]
24. [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics].
Scheen AJ; De Hert M
Rev Med Liege; 2005; 60(5-6):455-60. PubMed ID: 16035311
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.
McIntyre RS; McCann SM; Kennedy SH
Can J Psychiatry; 2001 Apr; 46(3):273-81. PubMed ID: 11320682
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study.
Lipscombe LL; Lévesque LE; Gruneir A; Fischer HD; Juurlink DN; Gill SS; Herrmann N; Hux JE; Anderson GM; Rochon PA
Am J Geriatr Psychiatry; 2011 Dec; 19(12):1026-33. PubMed ID: 22123274
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotics and venous thromboembolism risk: a meta-analysis.
Zhang R; Dong L; Shao F; Tan X; Ying K
Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
[TBL] [Abstract][Full Text] [Related]
28. Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications.
Ashim S; Warrington S; Anderson IM
J Psychopharmacol; 2004 Mar; 18(1):128-32. PubMed ID: 15107197
[TBL] [Abstract][Full Text] [Related]
29. [Antipsychotic drugs. Risk factors for diabetes].
Stip E; Tranulis C; Légaré N; Poulin MJ
Presse Med; 2003 Oct; 32(34):1612-7. PubMed ID: 14576587
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus associated with atypical anti-psychotic medications.
Clark C; Burge MR
Diabetes Technol Ther; 2003; 5(4):669-83. PubMed ID: 14511422
[TBL] [Abstract][Full Text] [Related]
31. The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents.
Citrome LL
Drugs Today (Barc); 2004 May; 40(5):445-64. PubMed ID: 15319799
[TBL] [Abstract][Full Text] [Related]
32. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.
Taylor D; Young C; Esop R; Paton C; Walwyn R
Br J Psychiatry; 2004 Aug; 185():152-6. PubMed ID: 15286067
[TBL] [Abstract][Full Text] [Related]
33. Diabetes mellitus and antipsychotic treatment in the United Kingdom.
Carlson C; Hornbuckle K; DeLisle F; Kryzhanovskaya L; Breier A; Cavazzoni P
Eur Neuropsychopharmacol; 2006 Jul; 16(5):366-75. PubMed ID: 16356695
[TBL] [Abstract][Full Text] [Related]
34. Care map. 2: Atypical antipsychotics. Diabetes and hyperglycaemia.
Houltram B; Scanlan M
Nurs Stand; 2004 Jun 2-8; 18(38):41-2. PubMed ID: 15199709
[No Abstract] [Full Text] [Related]
35. [Diabetes mellitus and atypical antipsychotics].
de Sena EP; Sampaio AS; Quarantini Lde C; Oliveira IR
Braz J Psychiatry; 2003 Oct; 25(4):253-7. PubMed ID: 15328554
[TBL] [Abstract][Full Text] [Related]
36. Clozapine use and risk of diabetes mellitus.
Wang PS; Glynn RJ; Ganz DA; Schneeweiss S; Levin R; Avorn J
J Clin Psychopharmacol; 2002 Jun; 22(3):236-43. PubMed ID: 12006892
[TBL] [Abstract][Full Text] [Related]
37. [Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations].
Jahn H; Schneider T
Nervenarzt; 2004 May; 75(5):442-50. PubMed ID: 15252884
[TBL] [Abstract][Full Text] [Related]
38. Can diabetes mellitus be induced by medication?
Saito E; Kafantaris V
J Child Adolesc Psychopharmacol; 2002; 12(3):231-6. PubMed ID: 12427296
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotics and the risk of diabetes: a general data review.
Bottai T; Quintin P; Perrin E
Eur Psychiatry; 2005 Dec; 20 Suppl 4():S349-57. PubMed ID: 16459250
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.
Holt RI; Peveler RC
Diabetologia; 2006 Jul; 49(7):1467-76. PubMed ID: 16752165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
